Observational studyRheumatology (Oxford, England)2022

Short- and longer-term cancer risks with biologic and targeted synthetic disease-modifying antirheumatic drugs as used against rheumatoid arthritis in clinical practice.

Viking Huss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.